title: Promoting Diabetic Wound Therapy Using Biodegradable rhPDGF-Loaded Nanofibrous Membranes: CONSORT-Compliant Article.
abstract: The nanofibrous biodegradable drug-loaded membranes that sustainably released recombinant human platelet-derived growth factor (rhPDGF-BB) to repair diabetic wounds were developed in this work.rhPDGF-BB and poly(lactic-co-glycolic acid) (PLGA) were mixed in hexafluoroisopropyl alcohol, followed by the electrospinning of the solutions into biodegradable membranes to equip the nanofibrous membranes. An elution technique and an enzyme-linked immunosorbent assay kit were used to determine the rhPDGF-BB release rates in vitro and in vivo from this membrane. Eighteen Sprague-Dawley streptozotocin-induced diabetic rats were randomized into 3 groups: rhPDGF-BB-loaded nanofibrous membrane group, PLGA only membrane group, and conventional gauze sponge group for the wound associated with diabetes of rat in each group.The nanofibrous biodegradable membranes released effective concentrations of rhPDGF-BB for over 21 days. The nanofibrous rhPDGF-BB-loaded PLGA membranes contained more water and were further hydrophilic than PLGA only fibers. The rhPDGF-BB-loaded PLGA membranes considerably helped the diabetic wounds repairing. Furthermore, the proliferative cells and angiogenesis of rats associated with diabetes by rhPDGF-BB-loaded nanofibrous membranes were greater than those of other groups, owing to the increased matrix metalloproteinase 9.These biodegradable rhPDGF-BB-loaded membranes were effective in treating diabetic wounds as very advanced accelerators during the initial phases of wound-healing process.
authors.affiliation: From the Division of Cardiology, Department of Internal Medicine (C-HL, S-HC, W-JC, K-CH, CC-C, P-CC), Department of Thoracic and Cardiovascular Surgery, Chang Gung Memorial Hospital-Linkou, Chang Gung University College of Medicine (K-SL), Department of Mechanical Engineering (S-JL), Graduate Institute of Clinical Medical Sciences, Chang Gung University (J-HSP), Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung University and Chang Gung Memorial Hospital, Tao-Yuan (J-HJ), Department of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan (Y-TC), and Shui-Mu Foundation of Chemistry, National Tsing Hua University, Hsinchu, Taiwan (F-SW).
authors.forename: Cheng-Hung
authors.initials: CH
authors.lastname: Lee
authors.forename: Kuo-Sheng
authors.initials: KS
authors.lastname: Liu
authors.forename: Shang-Hung
authors.initials: SH
authors.lastname: Chang
authors.forename: Wei-Jan
authors.initials: WJ
authors.lastname: Chen
authors.forename: Kuo-Chun
authors.initials: KC
authors.lastname: Hung
authors.forename: Shih-Jung
authors.initials: SJ
authors.lastname: Liu
authors.forename: Jong-Hwei S
authors.initials: JS
authors.lastname: Pang
authors.forename: Jyuhn-Huarng
authors.initials: JH
authors.lastname: Juang
authors.forename: Chung-Chuan
authors.initials: CC
authors.lastname: Chou
authors.forename: Po-Cheng
authors.initials: PC
authors.lastname: Chang
authors.forename: Yi-Ting
authors.initials: YT
authors.lastname: Chen
authors.forename: Fu-Shing
authors.initials: FS
authors.lastname: Wang
mesh_terms: D020341:Absorbable Implants; D000818:Animals; D000077214:Becaplermin; D003921:Diabetes Mellitus, Experimental; D004797:Enzyme-Linked Immunosorbent Assay; D005455:Fluorescent Antibody Technique; D006801:Humans; D019344:Lactic Acid / Q000494:pharmacology*; D008855:Microscopy, Electron, Scanning; D011100:Polyglycolic Acid / Q000494:pharmacology*; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D020574:Proto-Oncogene Proteins c-sis / Q000494:pharmacology*; D051381:Rats; D011913:Rats, Inbred BB; D017207:Rats, Sprague-Dawley; D014945:Wound Healing / Q000187:drug effects*
chemical_list: D020574:Proto-Oncogene Proteins c-sis; D000077214:Becaplermin; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D019344:Lactic Acid